``` REGISTERED COMPANY NUMBER: 01676618 (England and Wales) REGISTERED CHARITY NUMBER: 286197 ``` ``` Report of the Trustees and ``` ``` Unaudited Financial Statements for the Year Ended 31 December 2024 ``` ``` for ``` ``` British Toxicology Society(The) ``` ``` SMH BullockWoodburn Norfolk House Hardwick Square North Buxton SK17 6PU ``` ``` British Toxicology Society(The) ``` ## **`Contents of the Financial Statements for the Year Ended 31 December 2024`** ||**`Page`**| |---|---| |**`Report of the Trustees`**|`1 to 2`| |**`Independent Examiner's Report`**|`3`| |**`Statement of Financial Activities`**|`4`| |**`Balance Sheet`**|`5 to 6`| |**`Notes to the Financial Statements`**|`7 to 13`| |**`Detailed Statement of Financial Activities`**|`14 to 16`| ``` British Toxicology Society(The) ``` ## **`Report of the Trustees for the Year Ended 31 December 2024`** ``` ThetrusteeswhoarealsodirectorsofthecharityforthepurposesoftheCompaniesAct2006,presenttheir report withthefinancialstatementsofthecharityfortheyearended31December2024.Thetrusteeshaveadopted the provisionsofAccountingandReportingbyCharities:StatementofRecommendedPracticeapplicableto charities preparingtheiraccountsinaccordancewiththeFinancialReportingStandardapplicableintheUKandRepublic of Ireland (FRS 102) (effective 1 January 2019). ``` ## **`OBJECTIVES AND ACTIVITIES`** ## **`Objectives and significant activities`** ``` TheSocietyisestablishedforthepromotionandadvancement,forthepublicbenefit,ofeducationinthescience of toxicology.In decidingthe aims and activitiesof the society,the trusteeshave paiddue regardto the guidance issued by the CharityCommissionon publicbenefit.Toxicologyis the scienceof diseaseinducedby chemicalspresentin the diet,medicines,andintheenvironment.TheBritishToxicologySociety(BTS)isaleadinginternational toxicology society,basedonthehighestqualityscience,andpromotestheadvancement,communicationandunderstanding of the scientific disciplines necessary to foster public health and environmental safety. ``` ## **`STRUCTURE, GOVERNANCE AND MANAGEMENT`** ## **`Governing document`** ``` The Societyis a companylimitedby guaranteeandthe liabilityof members is limitedto an amountnot exceeding £1. ItisexemptunderSection60oftheCompaniesAct2006fromtherequirementtousetheword'Limited'inits title. TheSocietyisgovernedbytheMemorandumandArticlesofAssociation.Itisregisteredwiththe Charities Commission, number 286197, and no liability to taxation arises. ``` ``` TheExecutiveCommitteeareDirectorsforthepurposeofcompanylawandTrusteesforthepurposeofcharity law. Directors/TrusteesareappointedbytheSociety'smembersattheAnnualGeneralMeeting.WhenaTrustee retires, theExecutiveCommitteenominatesnewTrustees.Additionalnominationsmaybemadebythe membership, provided they are signed by six members of the Society. ``` ``` InformalinductionproceduresareinplacefornewTrustees,conductedbyanexistingmemberofthe Executive Committeeandtheyarealsoprovidedwithrelevantdocumentationtoformallyadviseandinformthemof the Society's constitution and objectives and also their duties and responsibilities as a trustee. ``` ``` OnethirdoftheExecutiveCommitteeordinarymembersretireeachyearinrotationbutaretheneligible for re-election.ThesocietyisorganisedsothattheTrustees,intheformoftheExecutiveCommittee,meet regularly, usuallyonaquarterlybasis,tomanageitsaffairs.Therearealsosub-committeeswhichareresponsiblefor advising and researching the various activities and development of the Society, who report to the Executive Committee. ``` ``` Statutesfor the workingsof the varioussub-committeesare continuallybeingrevisedand updatedto ensurethat the termsofreferenceareclearlydefinedandthewaysofworkingareconsistent.Thisalsoenablestransparency of committeeelectionsanddurationof membership,whileallowingthecommitteesto worktoagreedaims,backed up by comprehensive set of Standard Operating Procedures for the Society. ``` ``` ThetrusteeshaveassessedthemajorriskstowhichtheSocietyisexposed,inparticularthoserelatedto the operations and finances of the Society, and are satisfied that systems are in place to mitigate exposure to major risks. All of the officers and members who serve on the Society'scommitteesare unpaid.They are entitledto be reimbursed for any out of pocket expenses incurred in attending meetings. ``` ``` Norelatedparties,relatedpartytransactions,beneficialrelationshipsorconflictsofinterestrequiringdisclosure by the Charities' or Companies' Acts existed during the year. ``` ``` AttendancebyExecutiveCommitteemembershasbeenreasonablethroughouttheyear.Theco-opted members continue to provide liaison with the relevant Sub-Committees and Speciality Sections. ``` ``` The day to day administration of the Society is undertaken by an outside agency on a fee basis. ``` ## **`REFERENCE AND ADMINISTRATIVE DETAILS`** ## **`Registered Company number`** ``` 01676618 (England and Wales) ``` ## **`Registered Charity number`** ``` 286197 ``` ``` Page 1 ``` ``` British Toxicology Society(The) ``` ## **`Report of the Trustees for the Year Ended 31 December 2024`** ``` Registered office Executive Business Support Limited Stowe House St Chad's Road Lichfield Staffordshire WS13 6TJ ``` ``` Trustees Professor B G Lake Toxicologist (resigned 15/4/2024) Dr E Marczylo Toxicologist (resigned 15/4/2024) Dr D R Mason Toxicological Safety (resigned 15/4/2024) Professor S C Price Professor Of Toxicology Dr F Sewell Programme Manager Dr P A Botham Toxicologist Dr L M Reeve Toxicologist (resigned 15/4/2024) Dr I Copple Senior Lecturer in Pharmacology Dr B Ross Senior Consultant Toxicologist Dr H Matar Associate Professor of Toxicology Mrs F Hill Civil servant Dr E Idahosa-Taylor Toxicologist Prof V Stone Director (appointed 15/4/2024) Prof T Gant Head of Toxicology (appointed 15/4/2024) R Ghosh Principal Toxicologist (appointed 15/4/2024) ``` ``` Company Secretary Professor S C Price Independent Examiner Jonathon Dickens ACA SMH BullockWoodburn Norfolk House Hardwick Square North Buxton SK17 6PU ``` ``` Approved by order of the board of trustees on ............................................. and signed on its behalf by: ``` ``` ........................................................................ Mrs F Hill - Trustee ``` ``` Page 2 ``` ## **`Independent Examiner's Report to the Trustees of British Toxicology Society(The)`** ## **`Independent examiner's report to the trustees of British Toxicology Society(The) ('the Company')`** ``` IreporttothecharitytrusteesonmyexaminationoftheaccountsoftheCompanyfortheyear ended 31 December 2024. ``` ## **`Responsibilities and basis of report`** ``` As the charity'strusteesof the Company(andalsoits directorsfor the purposesof companylaw)youare responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act'). ``` ``` HavingsatisfiedmyselfthattheaccountsoftheCompanyarenotrequiredtobeauditedunderPart16ofthe 2006 Actandareeligibleforindependentexamination,I reportinrespectof my examinationof yourcharity'saccounts as carriedoutunderSection145oftheCharitiesAct2011('the2011Act').IncarryingoutmyexaminationI have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act. ``` ## **`Independent examiner's statement`** ``` Since yourcharity'sgross incomeexceeded£250,000yourexaminermust be a member of a listedbody.I can confirm thatIamqualifiedtoundertaketheexaminationbecauseIamamemberoftheAssociationofChartered Certified Accountants, which is one of the listed bodies. ``` ``` Ihavecompletedmyexamination.Iconfirmthatnomattershavecometomyattentioninconnectionwith the examination giving me cause to believe: ``` `1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or 2. the accounts do not accord with those records; or` `3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or` `4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).` ``` Ihavenoconcernsandhavecomeacrossnoothermattersinconnectionwiththeexaminationtowhich attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. ``` ## `Jonathon Dickens ACA` ``` SMH BullockWoodburn Norfolk House Hardwick Square North Buxton SK17 6PU ``` ``` 7 May 2025 ``` ``` Page 3 ``` ## **`British Toxicology Society(The)`** ## **`Statement of Financial Activities`** ## **`for the Year Ended 31 December 2024`** |`Unrestricted`
`fund`
`Notes`
`£`
**`INCOME AND ENDOWMENTS FROM`**
`Donations and legacies`
**`84,966`**
**`Charitable activities`**
`Annual Congress`
**`147,675`**
`Annual Congress trade exhibition`
**`3,360`**
`PATDD, ACT joint meetings, webinars and online`
`events`
**`10,622`**
`Other trading activities`
`2`
**`9,375`**
`Investment income`
`3`
**`12,549`**
**`Total`**
**`268,547`**
**`EXPENDITURE ON`**
`Raising funds`
`4`
**`25,430`**
**`Charitable activities`**
`5`
`Annual Congress`
**`156,817`**
`Annual Congress trade exhibition`
**`-`**
`PATDD, ACT joint meetings, webinars and online`
`events`
**`592`**
`Donations and subscriptions to other societies`
**`7,968`**
`Travel bursaries and early career support`
**`4,792`**
`Other`
**`62,867`**
**`Total`**
**`258,466`**
**`NET INCOME`**
**`10,081`**
**`RECONCILIATION OF FUNDS`**
`Total funds brought forward`
**`383,625`**
**`TOTAL FUNDS CARRIED FORWARD`**
**`393,706`**|`Restricted`
`funds`
`£`
**`5,000`**
**`-`**
**`-`**
**`-`**
**`-`**
**`285`**
**`5,285`**
**`-`**
**`-`**
**`-`**
**`-`**
**`-`**
**`75`**
**`-`**
**`75`**
**`5,210`**
**`10,104`**
**`15,314`**|**`2024`**
**`Total`**
**`funds`**
**`£`**
**`89,966`**
**`147,675`**
**`3,360`**
**`10,622`**
**`9,375`**
**`12,834`**
**`273,832`**
**`25,430`**
**`156,817`**
**`-`**
**`592`**
**`7,968`**
**`4,867`**
**`62,867`**
**`258,541`**
**`15,291`**
**`393,729`**
**`409,020`**|`2023`
`Total`
`funds`
`£`
`73,364`
`122,191`
`3,970`
`10,790`
`11,487`
`7,468`| |---|---|---|---| ||||`229,270`| ||||`22,404`
`137,856`
`107`
`-`
`7,232`
`7,701`
`43,669`| ||||`218,969`| ||||`10,301`
`383,428`| ||||`393,729`| ``` The notes form part of these financial statements ``` ``` Page 4 ``` ``` British Toxicology Society(The) ``` ## **`Balance Sheet`** ## **`31 December 2024`** |`Unrestricted`
`fund`
`Notes`
`£`
**`CURRENT ASSETS`**
`Debtors`
`9`
**`74,282`**
`Cash at bank`
**`342,841`**
**`417,123`**
**`CREDITORS`**
`Amounts falling due within one year`
`10`
**`(23,417)`**
**`NET CURRENT ASSETS`**
**`393,706`**
**`TOTAL ASSETS LESS CURRENT LIABILITIES`**
**`393,706`**
**`NET ASSETS`**
**`393,706`**
**`FUNDS`**
`11`
`Unrestricted funds`
`Restricted funds`
**`TOTAL FUNDS`**|`Restricted`
`funds`
`£`
**`-`**
**`15,314`**
**`15,314`**
**`-`**
**`15,314`**
**`15,314`**
**`15,314`**|**`2024`**
**`Total`**
**`funds`**
**`£`**
**`74,282`**
**`358,155`**
**`432,437`**
**`(23,417)`**
**`409,020`**
**`409,020`**
**`409,020`**
**`393,706`**
**`15,314`**
**`409,020`**|`2023`
`Total`
`funds`
`£`
`65,125`
`397,599`
`462,724`
`(68,995)`
`393,729`
`393,729`
`393,729`
`383,625`
`10,104`
`393,729`| |---|---|---|---| ``` The charitablecompanyis entitledto exemptionfrom audit under Section477 of the CompaniesAct 2006 for the year ended 31 December 2024. ``` ``` Themembershavenotrequiredthecompanytoobtainanauditofitsfinancialstatementsfortheyear ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006. ``` ``` The trustees acknowledge their responsibilities for ``` - `(a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and` - `(b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.` ``` The notes form part of these financial statements ``` ``` continued... ``` ``` Page 5 ``` ``` British Toxicology Society(The) ``` ## **`Balance Sheet - continued`** ## **`31 December 2024`** ``` Thesefinancialstatementshavebeenpreparedinaccordancewiththeprovisionsapplicabletocharitable companies subject to the small companies regime. ``` ``` ThefinancialstatementswereapprovedbytheBoardofTrusteesandauthorisedforissue on ............................................. and were signed on its behalf by: ``` ``` ............................................. F Hill - Trustee ``` ``` ............................................. S C Price - Trustee ``` ``` The notes form part of these financial statements ``` ``` Page 6 ``` ``` British Toxicology Society(The) ``` ## **`Notes to the Financial Statements`** ## **`for the Year Ended 31 December 2024`** ## **`1. ACCOUNTING POLICIES`** ## **`Basis of preparing the financial statements`** ``` The financialstatementsof the charitablecompany,whichis a publicbenefitentityunderFRS 102,have been preparedinaccordancewiththeCharitiesSORP(FRS102)'AccountingandReportingbyCharities: Statement ofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsinaccordancewiththe Financial ReportingStandardapplicablein the UK and Republicof Ireland(FRS 102) (effective1 January2019)', Financial ReportingStandard102 'The FinancialReportingStandardapplicablein the UK and Republicof Ireland'and the Companies Act 2006. The financial statements have been prepared under the historical cost convention. ``` ## **`Going concern`** ``` There are no material uncertainties about the charity's ability to continue. Thetrustees'assessmentoftherisksassociatedwithBrexitandthepandemicaredetailedinthe President's report. ``` ## **`Financial reporting standard 102 - reduced disclosure exemptions`** ``` Thecharitablecompanyhastakenadvantageofthefollowingdisclosureexemptionsinpreparing these financialstatements,aspermittedbyFRS102'TheFinancialReportingStandardapplicableintheUK and Republic of Ireland': ``` - `the requirements of Section 7 Statement of Cash Flows;` - `the requirement of paragraph 3.17(d);` - `the requirements of paragraphs 11.42, 11.44, 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);` - `the requirements of paragraphs 12.26, 12.27, 12.29(a), 12.29(b) and 12.29A;` - `the requirement of paragraph 33.7.` ## **`Income`** ``` All incomingresourcesare includedin the statementof financialactivitieswhen entitlementhas passedto the charity;itisprobablethattheeconomicbenefitsassociatedwiththetransactionwillflowtothecharity and theamountcanbereliablymeasured.Thefollowingspecificpoliciesareappliedtoparticularcategories of income: ``` ``` -Incomefromdonationsorgrantsisrecognisedwhenthereisevidenceofentitlementtothegift,receipt is probable and its amount can be measured reliably. ``` ``` - Legacy income is recognised when receipt is probable and entitlement is established. ``` ``` - Incomefromdonatedgoodsismeasuredatthefairvalueofthegoodsunlessthisisimpracticalto measure reliably,inwhichcasethevalueisderivedfromthecosttothedonorortheestimatedresalevalue. Donated facilitiesandservicesarerecognisedintheaccountswhenreceivedifthevaluecanbereliablymeasured. No amounts are included for the contribution of general volunteers. ``` ``` - Income from contractsfor the supplyof services is recognisedwith the delivery of the contractedservice. This isclassifiedasunrestrictedfundsunlessthereisacontractualrequirementforittobespentona particular purpose and returned if unspent, in which case it may be regarded as restricted. ``` ## **`Expenditure`** ``` Expenditureisrecognisedonanaccrualsbasisasaliabilityisincurred.ExpenditureincludesanyVAT which cannotbefullyrecovered,andisclassifiedunderheadingsofthestatementoffinancialactivitiestowhich it relates: ``` ``` -Expenditureonraisingfundsincludesthecostsofallfundraisingactivities,events,non-charitable trading activities, and the sale of donated goods. ``` ``` continued... ``` ``` Page 7 ``` ``` British Toxicology Society(The) ``` ## **`Notes to the Financial Statements - continued`** ## **`for the Year Ended 31 December 2024`** ## **`1. ACCOUNTING POLICIES - continued`** ## **`Expenditure`** ``` -Expenditureoncharitableactivitiesincludesallcostsincurredbyacharityinundertakingactivities that furtherits charitableaims for the benefit of its beneficiaries,includingthose supportcosts and costs relating to the governance of the charity apportioned to charitable activities. ``` ``` - Otherexpenditureincludesallexpenditurethatis neitherrelatedtoraisingfundsforthecharitynorpart of its expenditure on charitable activities. ``` ``` All costsare allocatedto expenditurecategoriesreflectingthe use of the resource.Directcostsattributable to a singleactivityare allocateddirectlyto that activity.Sharedcosts are apportionedbetweenthe activities they contribute to on a reasonable, justifiable and consistent basis. ``` ## **`Taxation`** ``` The charity is exempt from corporation tax on its charitable activities. ``` ## **`Fund accounting`** ``` Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. ``` ``` Restrictedfundscanonlybeusedforparticularrestrictedpurposeswithintheobjectsofthe charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. ``` ``` Furtherexplanationofthenatureandpurposeofeachfundisincludedinthenotestothe financial statements. ``` ## **`2. OTHER TRADING ACTIVITIES`** |**`OTHER TRADING ACTIVITIES`**||| |---|---|---| |`Unrestricted`
`Restricted`
`funds`
`funds`
`£`
`£`
`Website advertising`
**`7,875`**
**`-`**
`OUP / RSC Journal income`
**`1,500`**
**`-`**
**`9,375`**
**`-`**|**`2024`**
**`Total`**
**`funds`**
**`£`**
**`7,875`**
**`1,500`**
**`9,375`**|`2023`
`Total`
`funds`
`£`
`9,667`
`1,820`| |||`11,487`| ## **`3. INVESTMENT INCOME`** |**`INVESTMENT INCOME`**||||| |---|---|---|---|---| ||||**`2024`**|`2023`| ||`Unrestricted`|`Restricted`|**`Total`**|`Total`| ||`funds`|`funds`|**`funds`**|`funds`| ||`£`|`£`|**`£`**|`£`| |`Deposit account interest`|**`12,549`**|**`285`**|**`12,834`**|`7,468`| ``` continued... ``` ``` Page 8 ``` ``` British Toxicology Society(The) ``` ## **`Notes to the Financial Statements - continued`** ## **`for the Year Ended 31 December 2024`** ## **`4. RAISING FUNDS`** ## **`Raising donations and legacies`** |**`Raising donations and legacies`**||||| |---|---|---|---|---| |`Unrestricted`
`funds`
`£`
`Bank charges`
**`1,972`**
`EBS - membership processing`
**`12,226`**
`Support costs`
**`8,084`**
**`22,282`**
**`Other trading activities`**
`Unrestricted`
`funds`
`£`
`ACT webinars`
**`-`**
`Bank charges`
**`43`**
`Speciality section meetings`
**`1,100`**
`Joint BPS-BTS meeting`
**`2,005`**
`Support costs`
**`-`**
**`3,148`**
`Aggregate amounts`
**`25,430`**
**`5.`**
**`CHARITABLE ACTIVITIES COSTS`**
`Annual Congress`
`PATDD, ACT joint meetings, webinars`
`and online events`
`Donations and subscriptions to other`
`societies`
`Travel bursaries and early career`
`support`|`Restricted`
`funds`
`£`
**`-`**
**`-`**
**`-`**
**`-`**
`Restricted`
`funds`
`£`
**`-`**
**`-`**
**`-`**
**`-`**
**`-`**
**`-`**
**`-`**
`Direct`
`Costs`
`£`
**`124,172`**
**`592`**
**`6,121`**
**`4,867`**
**`135,752`**|**`2024`**
**`Total`**
**`funds`**
**`£`**
**`1,972`**
**`12,226`**
**`8,084`**
**`22,282`**
**`2024`**
**`Total`**
**`funds`**
**`£`**
**`-`**
**`43`**
**`1,100`**
**`2,005`**
**`-`**
**`3,148`**
**`25,430`**
`Support`
`costs (see`
`note 6)`
`£`
**`32,645`**
**`-`**
**`1,847`**
**`-`**
**`34,492`**|`2023`
`Total`
`funds`
`£`
`1,151`
`11,677`
`7,721`
`20,549`
`2023`
`Total`
`funds`
`£`
`1,015`
`90`
`-`
`-`
`750`
`1,855`
`22,404`
`Totals`
`£`
**`156,817`**
**`592`**
**`7,968`**
**`4,867`**|`2023`
`Total`
`funds`
`£`
`1,151`
`11,677`
`7,721`| |||||`20,549`| |||||`2023`
`Total`
`funds`
`£`
`1,015`
`90`
`-`
`-`
`750`
`1,855`
`22,404`| ||||**`170,244`**|| ``` continued... ``` ``` Page 9 ``` ``` British Toxicology Society(The) ``` ## **`Notes to the Financial Statements - continued for the Year Ended 31 December 2024`** ## **`6. SUPPORT COSTS`** |`Management`
`£`
`Raising donations and`
`legacies`
**`-`**
`Other resources expended`
**`9,046`**
`Annual Congress`
**`145`**
`Donations and`
`subscriptions to other`
`societies`
**`-`**
**`9,191`**|`Information`
`Governance`
`Finance`
`technology`
`costs`
`£`
`£`
`£`
**`8,084`**
**`-`**
**`-`**
**`6,739`**
**`39,417`**
**`7,665`**
**`-`**
**`-`**
**`32,500`**
**`1,347`**
**`500`**
**`-`**
**`16,170`**
**`39,917`**
**`40,165`**|`Totals`
`£`
**`8,084`**
**`62,867`**
**`32,645`**
**`1,847`**| |---|---|---| |||**`105,443`**| ## **`7. TRUSTEES' REMUNERATION AND BENEFITS`** ``` There were no trustees'remunerationor other benefitsfor the year ended 31 December 2024 nor for the year ended 31 December 2023. ``` ## **`Trustees' expenses`** |**`Trustees' expenses`**|||| |---|---|---|---| |`Trustees' expenses`
**`8.`**
**`COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES`**
`Unrestricted`
`fund`
`£`
**`INCOME AND ENDOWMENTS FROM`**
`Donations and legacies`
`73,364`
**`Charitable activities`**
`Annual Congress`
`122,191`
`Annual Congress trade exhibition`
`3,970`
`PATDD, ACT joint meetings, webinars and`
`online events`
`10,790`
`Other trading activities`
`11,487`
`Investment income`
`7,378`
**`Total`**
`229,180`
**`EXPENDITURE ON`**
`Raising funds`
`22,404`
**`Charitable activities`**
`Annual Congress`
`137,856`
`Annual Congress trade exhibition`
`107`
`Donations and subscriptions to other`
`societies`
`7,232`
`Travel bursaries and early career support`
`7,701`
`Other`
`43,669`|**`2024`**
**`£`**
**`1,068`**
`Restricted`
`funds`
`£`
`-`
`-`
`-`
`-`
`-`
`90`
`90`
`-`
`-`
`-`
`-`
`-`
`-`|`2023`
`£`
`187`
`Total`
`funds`
`£`
`73,364`
`122,191`
`3,970`
`10,790`
`11,487`
`7,468`|| ||||`229,270`| ||||`22,404`
`137,856`
`107`
`7,232`
`7,701`
`43,669`| ``` continued... ``` ``` Page 10 ``` ``` British Toxicology Society(The) ``` ## **`Notes to the Financial Statements - continued for the Year Ended 31 December 2024`** |**`8.`**
**`COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued`**
`Unrestricted`
`fund`
`£`
**`Total`**
`218,969`
**`NET INCOME`**
`10,211`
**`RECONCILIATION OF FUNDS`**
`Total funds brought forward`
`373,414`
**`TOTAL FUNDS CARRIED FORWARD`**
`383,625`
**`9.`**
**`DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**
`Debtors`
`Prepayments & accrued income`
**`10.`**
**`CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**
`Trade creditors`
`Accruals & prepaid income`
**`11.`**
**`MOVEMENT IN FUNDS`**
`At 1/1/24`
`£`
**`Unrestricted funds`**
`General fund`
**`383,625`**
**`Restricted funds`**
`Barnes fund`
**`814`**
`Paton fund`
**`3,812`**
`Norman Aldridge fund`
**`5,478`**
**`10,104`**
**`TOTAL FUNDS`**
**`393,729`**|`Restricted`
`funds`
`£`
`-`
`90`
`10,014`
`10,104`
**`2024`**
**`£`**
**`11,140`**
**`63,142`**
**`74,282`**
**`2024`**
**`£`**
**`5,521`**
**`17,896`**
**`23,417`**
`Net`
`movement`
`in funds`
`£`
**`10,081`**
**`22`**
**`107`**
**`5,081`**
**`5,210`**
**`15,291`**|`Total`
`funds`
`£`
`218,969`
`10,301`
`383,428`
`393,729`
`2023`
`£`
`6,073`
`59,052`
`65,125`
`2023`
`£`
`52,680`
`16,315`
`68,995`
`At`
`31/12/24`
`£`
**`393,706`**
**`836`**
**`3,919`**
**`10,559`**
**`15,314`**
**`409,020`**|`Total`
`funds`
`£`| |---|---|---|---| ||||`218,969`| ||||`10,301`
`383,428`| ||||`393,729`| ``` continued... ``` ``` Page 11 ``` ``` British Toxicology Society(The) ``` ## **`Notes to the Financial Statements - continued`** ## **`for the Year Ended 31 December 2024`** ## **`11. MOVEMENT IN FUNDS - continued`** ``` Net movement in funds, included in the above are as follows: ``` |**`Unrestricted funds`**
`General fund`
**`Restricted funds`**
`Barnes fund`
`Paton fund`
`Norman Aldridge fund`
**`TOTAL FUNDS`**|`Incoming`
`resources`
`£`
**`268,547`**
**`22`**
**`107`**
**`5,156`**
**`5,285`**
**`273,832`**|`Resources`
`Movement`
`expended`
`in funds`
`£`
`£`
**`(258,466)`**
**`10,081`**
**`-`**
**`22`**
**`-`**
**`107`**
**`(75)`**
**`5,081`**
**`(75)`**
**`5,210`**
**`(258,541)`**
**`15,291`**| |---|---|---| ## **`Comparatives for movement in funds`** |**`Unrestricted funds`**
`General fund`
**`Restricted funds`**
`Barnes fund`
`Paton fund`
`Norman Aldridge fund`
**`TOTAL FUNDS`**|`At 1/1/23`
`£`
`373,414`
`813`
`3,777`
`5,424`
`10,014`
`383,428`|`Net`
`movement`
`in funds`
`£`
`10,211`
`1`
`35`
`54`
`90`
`10,301`|`At`
`31/12/23`
`£`
`383,625`
`814`
`3,812`
`5,478`| |---|---|---|---| ||||`10,104`| ||||`393,729`| ``` continued... ``` ``` Page 12 ``` ``` British Toxicology Society(The) ``` ## **`Notes to the Financial Statements - continued`** ## **`for the Year Ended 31 December 2024`** ## **`11. MOVEMENT IN FUNDS - continued`** ``` Comparative net movement in funds, included in the above are as follows: ``` |**`Unrestricted funds`**
`General fund`
**`Restricted funds`**
`Barnes fund`
`Paton fund`
`Norman Aldridge fund`
**`TOTAL FUNDS`**|`Incoming`
`resources`
`£`
`229,180`
`1`
`35`
`54`
`90`
`229,270`|`Resources`
`Movement`
`expended`
`in funds`
`£`
`£`
`(218,969)`
`10,211`
`-`
`1`
`-`
`35`
`-`
`54`
`-`
`90`
`(218,969)`
`10,301`| |---|---|---| ``` Restrictedfundscomprisedonationsgiven to providelectureawards,travelgrantsand supportto early career toxicologists. Awards are made by the trustees on an alternate year basis. ``` ## **`12. RELATED PARTY DISCLOSURES`** ``` There were no related party transactions. ``` ``` Page 13 ``` ``` British Toxicology Society(The) ``` ## **`Detailed Statement of Financial Activities for the Year Ended 31 December 2024`** |`Unrestricted`
`Restricted`
`funds`
`funds`
`£`
`£`
**`INCOME AND ENDOWMENTS`**
**`Donations and legacies`**
`Donations`
**`21,977`**
**`5,000`**
`Subscriptions`
**`62,989`**
**`-`**
**`84,966`**
**`5,000`**
**`Other trading activities`**
`Website advertising`
**`7,875`**
**`-`**
`OUP / RSC Journal income`
**`1,500`**
**`-`**
**`9,375`**
**`-`**
**`Investment income`**
`Deposit account interest`
**`12,549`**
**`285`**
**`Charitable activities`**
`Annual Congress delegates`
**`107,975`**
**`-`**
`Annual Congress donations`
**`4,450`**
**`-`**
`Annual Congress exhibitors and trade stands`
**`3,360`**
**`-`**
`PATDD & ACT joint meetings & webinars`
**`10,622`**
**`-`**
`BTS skills gap registration`
**`29,400`**
**`-`**
`Discovery Toxicology sponsorship`
**`5,850`**
**`-`**
**`161,657`**
**`-`**
**`Total incoming resources`**
**`268,547`**
**`5,285`**
**`EXPENDITURE`**
**`Raising donations and legacies`**
`Bank charges`
**`1,972`**
**`-`**
`EBS - membership processing`
**`12,226`**
**`-`**
**`14,198`**
**`-`**
**`Other trading activities`**
`ACT webinars`
**`-`**
**`-`**
`Bank charges`
**`43`**
**`-`**
`Speciality section meetings`
**`1,100`**
**`-`**
`Joint BPS-BTS meeting`
**`2,005`**
**`-`**
**`3,148`**
**`-`**|`2024`
`Total`
`funds`
`£`
**`26,977`**
**`62,989`**
**`89,966`**
**`7,875`**
**`1,500`**
**`9,375`**
**`12,834`**
**`107,975`**
**`4,450`**
**`3,360`**
**`10,622`**
**`29,400`**
**`5,850`**
**`161,657`**
**`273,832`**
**`1,972`**
**`12,226`**
**`14,198`**
**`-`**
**`43`**
**`1,100`**
**`2,005`**
**`3,148`**|`2023`
`Total`
`funds`
`£`
`13,000`
`60,364`| |---|---|---| |||`73,364`
`9,667`
`1,820`| |||`11,487`
`7,468`
`117,881`
`5,100`
`3,970`
`10,000`
`-`
`-`| |||`136,951`| |||`229,270`
`1,151`
`11,677`| |||`12,828`
`1,015`
`90`
`-`
`-`| |||`1,105`| ``` This page does not form part of the statutory financial statements ``` ``` Page 14 ``` ## **`British Toxicology Society(The)`** ## **`Detailed Statement of Financial Activities for the Year Ended 31 December 2024`** |`Unrestricted`
`Restricted`
`funds`
`funds`
`£`
`£`
**`Other trading activities`**
**`Charitable activities`**
`Insurance`
**`1,183`**
**`-`**
`Entertainment`
**`1,650`**
**`-`**
`Security`
**`1,122`**
**`-`**
`Speakers' expenses`
**`4,615`**
**`-`**
`Delegate materials`
**`228`**
**`-`**
`Accommodation and meals`
**`96,058`**
**`-`**
`Technicians and equipment hire`
**`7,021`**
**`-`**
`Bank charges`
**`652`**
**`75`**
`EBS management fee`
**`8,089`**
**`-`**
`EBS travel expenses`
**`294`**
**`-`**
`EBS processing fees`
**`2,763`**
**`-`**
`Eurotox subscription`
**`1,702`**
**`-`**
`Understanding Animal Research`
**`665`**
**`-`**
`Society of Biology`
**`760`**
**`-`**
`Iutox International`
**`2,828`**
**`-`**
`Early career prizes`
**`664`**
**`-`**
`Travel bursary`
**`3,232`**
**`-`**
`Studentship`
**`1,500`**
**`-`**
`Oral presentation prize`
**`200`**
**`-`**
`Recognition awards`
**`9`**
**`-`**
`Poster presentation prize`
**`400`**
**`-`**
`NEST promotional materials`
**`42`**
**`-`**
**`135,677`**
**`75`**
**`Support costs`**
**`Management`**
`Postage and stationery`
**`507`**
**`-`**
`EBS- trustee support`
**`8,684`**
**`-`**
**`9,191`**
**`-`**
**`Finance`**
`EBS- bookkeeping & finance`
**`16,170`**
**`-`**
**`Information technology`**
`EBS - website management`
**`36,689`**
**`-`**
`EBS- licences & IT support`
**`2,728`**
**`-`**
`EDIS membership contribution`
**`500`**
**`-`**
**`39,917`**
**`-`**
**`Other`**
`Provision for doubtful debt`
**`-`**
**`-`**|`2024`
`Total`
`funds`
`£`
**`1,183`**
**`1,650`**
**`1,122`**
**`4,615`**
**`228`**
**`96,058`**
**`7,021`**
**`727`**
**`8,089`**
**`294`**
**`2,763`**
**`1,702`**
**`665`**
**`760`**
**`2,828`**
**`664`**
**`3,232`**
**`1,500`**
**`200`**
**`9`**
**`400`**
**`42`**
**`135,752`**
**`507`**
**`8,684`**
**`9,191`**
**`16,170`**
**`36,689`**
**`2,728`**
**`500`**
**`39,917`**
**`-`**|`2023`
`Total`
`funds`
`£`
`1,338`
`1,841`
`-`
`3,748`
`991`
`93,086`
`15,017`
`288`
`17,892`
`192`
`3,179`
`1,910`
`291`
`660`
`3,032`
`-`
`6,587`
`-`
`300`
`653`
`100`
`461`| |---|---|---| |||`151,566`
`214`
`8,293`| |||`8,507`
`15,443`
`20,059`
`2,686`
`-`| |||`22,745`
`750`| ``` This page does not form part of the statutory financial statements ``` ``` Page 15 ``` ``` British Toxicology Society(The) ``` ## **`Detailed Statement of Financial Activities for the Year Ended 31 December 2024`** |**`Detailed Statement of Financial Activities`**
**`for the Year Ended 31 December 2024`**||| |---|---|---| |`Unrestricted`
`Restricted`
`funds`
`funds`
`£`
`£`
**`Other`**
**`Governance costs`**
`Meeting expenses - trustees`
**`1,068`**
**`-`**
`Accountancy fees`
**`6,478`**
**`-`**
`Meeting expenses- non trustees`
**`119`**
**`-`**
`Project co-ordinator`
**`32,500`**
**`-`**
**`40,165`**
**`-`**
`Total resources expended`
**`258,466`**
**`75`**
**`Net income`**
**`10,081`**
**`5,210`**|`2024`
`Total`
`funds`
`£`
**`1,068`**
**`6,478`**
**`119`**
**`32,500`**
**`40,165`**
**`258,541`**
**`15,291`**|`2023`
`Total`
`funds`
`£`
`187`
`5,415`
`423`
`-`| |||`6,025`| |||`218,969`| |||`10,301`| ``` This page does not form part of the statutory financial statements ``` ``` Page 16 ```